Moreover, from the post hoc analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy in diabetic CKD patients with anemia, higher baseline CRP levels, known as inflammation biomarkers, were associated with a greater risk of future ESRD, whereas higher HbA1c levels did not present the association[40]. The gene discussed is CRP; the disease is anemia (phenotype).